Ahmedabad: Zydus, a discovery-based, global pharmaceutical company has announced that the U.S. Food and Drug Administration ...

Zydus has announced that the USFDA has granted Orphan Drug Designation (ODD) to Usnoflast, a novel oral NLRP3 inhibitor, for ...

Zydus Lifesciences announced that the USFDA granted Orphan Drug Designation to Usnoflast, a novel oral NLRP3 inhibitor, for ...

Zydus Lifesciences's Usnoflast receives Orphan Drug Designation from the USFDA for the treatment of Amyotrophic Lateral ...

Zydus’ Usnoflast receives US FDA orphan drug designation to treat amyotrophic lateral sclerosis: Our Bureau, Mumbai Thursday, January 23, 2025, 12:15 Hrs [IST] Zydus, a leading, ...

“Traditional network deployments demand labor-intensive configuration and validation. Nile Nav automates these steps, ...

The Centre for Management of Health Services CMHS and the AlumniampExternal Relations Office at the Indian Institute of ...

Zydus Lifesciences announced that Usnoflast, a treatment for amyotrophic lateral sclerosis (ALS), has received Orphan Drug Designation from the US FDA. This designation supports the development of ...

The US Food and Drug Administration (FDA) has granted approval for Zydus Lifesciences to proceed with a randomised Phase IIb ...

Shardul Nautiyal, Mumbai Wednesday, January 22, 2025, 08:00 Hrs [IST] ...

Kanpur: Samajwadi Party's president Akhilesh Yadav on Monday attended the ritual to pay tribute to his uncle Rajpal Yadav, ...

Hyderabad: Amid rising vehicular and industrial pollution in the city, a study by the Institute of Forest Biodiversity, ...